121 related articles for article (PubMed ID: 9835072)
1. Structural elucidation by electrospray mass spectrometry: an approach to the in vitro metabolism of the macrolide immunosuppressant SDZ RAD.
Vidal C; Kirchner GI; Sewing KF
J Am Soc Mass Spectrom; 1998 Dec; 9(12):1267-74. PubMed ID: 9835072
[TBL] [Abstract][Full Text] [Related]
2. Identification of a new metabolite of macrolide immunosuppressant, like rapamycin and SDZ RAD, using high performance liquid chromatography and electrospray tandem mass spectrometry.
Hallensleben K; Raida M; Habermehl G
J Am Soc Mass Spectrom; 2000 Jun; 11(6):516-25. PubMed ID: 10833025
[TBL] [Abstract][Full Text] [Related]
3. Isolation from pig liver microsomes, identification by tandem mass spectrometry and in vitro immunosuppressive activity of an SDZ-RAD 17,18,19,20,21,22-tris-epoxide.
Lhoëst GJ; Gougnard TY; Verbeeck RK; Maton N; Dehoux JP; Wallemacq P; Schüler W; Latinne D
J Mass Spectrom; 2000 Mar; 35(3):454-60. PubMed ID: 10767777
[TBL] [Abstract][Full Text] [Related]
4. LC/ESI-MS allows simultaneous and specific quantification of SDZ RAD and cyclosporine, including groups of their metabolites in human blood.
Kirchner GI; Vidal C; Winkler M; Mueller L; Jacobsen W; Franzke A; Sewing KF
Ther Drug Monit; 1999 Feb; 21(1):116-22. PubMed ID: 10051064
[TBL] [Abstract][Full Text] [Related]
5. Assessment and validation of the MS/MS fragmentation patterns of the macrolide immunosuppressant everolimus.
Boernsen KO; Egge-Jacobsen W; Inverardi B; Strom T; Streit F; Schiebel HM; Benet LZ; Christians U
J Mass Spectrom; 2007 Jun; 42(6):793-802. PubMed ID: 17511017
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of SDZ RAD and cyclosporin including their metabolites in seven kidney graft patients after the first dose of SDZ RAD.
Kirchner GI; Winkler M; Mueller L; Vidal C; Jacobsen W; Franzke A; Wagner S; Blick S; Manns MP; Sewing KF
Br J Clin Pharmacol; 2000 Nov; 50(5):449-54. PubMed ID: 11069439
[TBL] [Abstract][Full Text] [Related]
7. Structural identification of three metabolites and a degradation product of the macrolide immunosuppressant sirolimus (rapamycin) by electrospray-MS/MS after incubation with human liver microsomes.
Streit F; Christians U; Schiebel HM; Meyer A; Sewing KF
Drug Metab Dispos; 1996 Nov; 24(11):1272-8. PubMed ID: 8937863
[TBL] [Abstract][Full Text] [Related]
8. In vitro biotransformation of SDZ RAD: a new immunosuppressive macrolide in human liver microsomal preparations.
Dannecker R; Vickers AE; Ubeaud G; Hauck C
Transplant Proc; 1998 Aug; 30(5):2206. PubMed ID: 9723442
[TBL] [Abstract][Full Text] [Related]
9. Development of a high-performance liquid chromatographic-electrospray mass spectrometric assay for the specific and sensitive quantification of the novel immunosuppressive macrolide 40-O-(2-hydroxyethyl)rapamycin.
Segarra I; Brazelton TR; Guterman N; Hausen B; Jacobsen W; Morris RE; Benet LZ; Christians U
J Chromatogr B Biomed Sci Appl; 1998 Dec; 720(1-2):179-87. PubMed ID: 9892080
[TBL] [Abstract][Full Text] [Related]
10. The novel immunosuppressant SDZ-RAD protects rat brain slices from cyclosporine-induced reduction of high-energy phosphates.
Serkova N; Litt L; Leibfritz D; Hausen B; Morris RE; James TL; Benet LZ; Christians U
Br J Pharmacol; 2000 Feb; 129(3):485-92. PubMed ID: 10711346
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the in vitro metabolism of the macrolide immunosuppressants sirolimus and RAD.
Jacobsen W; Serkova N; Hausen B; Morris RE; Benet LZ; Christians U
Transplant Proc; 2001; 33(1-2):514-5. PubMed ID: 11266932
[No Abstract] [Full Text] [Related]
12. In vitro immunosuppressive activity of tacrolimus dihydrodiol precursors obtained by chemical oxidation and identification of a new metabolite of SDZ-RAD by electrospray and electrospray-linked scan mass spectrometry.
Lhoëst G; Hertsens R; Verbeeck RK; Maton N; Wallemacq P; Dehoux JP; Latinne D
J Mass Spectrom; 2001 Aug; 36(8):889-901. PubMed ID: 11523088
[TBL] [Abstract][Full Text] [Related]
13. Crossreactivity of isolated everolimus metabolites with the Innofluor Certican immunoassay for therapeutic drug monitoring of everolimus.
Strom T; Haschke M; Boyd J; Roberts M; Arabshahi L; Marbach P; Christians U
Ther Drug Monit; 2007 Dec; 29(6):743-9. PubMed ID: 18043471
[TBL] [Abstract][Full Text] [Related]
14. Automated simultaneous quantification of the immunosuppressants 40-O-(2-hydroxyethyl) rapamycin and cyclosporine in blood with electrospray-mass spectrometric detection.
Vidal C; Kirchner GI; Wünsch G; Sewing KF
Clin Chem; 1998 Jun; 44(6 Pt 1):1275-82. PubMed ID: 9625053
[TBL] [Abstract][Full Text] [Related]
15. In vitro metabolic study of temsirolimus: preparation, isolation, and identification of the metabolites.
Cai P; Tsao R; Ruppen ME
Drug Metab Dispos; 2007 Sep; 35(9):1554-63. PubMed ID: 17540708
[TBL] [Abstract][Full Text] [Related]
16. Tissue distribution and clinical monitoring of the novel macrolide immunosuppressant SDZ-RAD and its metabolites in monkey lung transplant recipients: interaction with cyclosporine.
Serkova N; Hausen B; Berry GJ; Jacobsen W; Benet LZ; Morris RE; Christians U
J Pharmacol Exp Ther; 2000 Jul; 294(1):323-32. PubMed ID: 10871329
[TBL] [Abstract][Full Text] [Related]
17. Structural identification of SAR-943 metabolites generated by human liver microsomes in vitro using mass spectrometry in combination with analysis of fragmentation patterns.
Strom T; Shokati T; Klawitter J; Klawitter J; Hoffman K; Schiebel HM; Christians U
J Mass Spectrom; 2011 Jul; 46(7):615-24. PubMed ID: 21671437
[TBL] [Abstract][Full Text] [Related]
18. Identification of everolimus metabolite patterns in trough blood samples of kidney transplant patients.
Strom T; Haschke M; Zhang YL; Bendrick-Peart J; Boyd J; Roberts M; Arabshahi L; Marbach P; Christians U
Ther Drug Monit; 2007 Oct; 29(5):592-9. PubMed ID: 17898649
[TBL] [Abstract][Full Text] [Related]
19. Quantification and stability of everolimus (SDZ RAD) in human blood by high-performance liquid chromatography-electrospray tandem mass spectrometry.
Salm P; Taylor PJ; Lynch SV; Pillans PI
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Jun; 772(2):283-90. PubMed ID: 12007773
[TBL] [Abstract][Full Text] [Related]
20. Sensitive, high throughput HPLC-MS/MS method with on-line sample clean-up for everolimus measurement.
Korecka M; Solari SG; Shaw LM
Ther Drug Monit; 2006 Aug; 28(4):484-90. PubMed ID: 16885715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
